Danaher's Q3 Results Beat On Top And Bottom Lines
Date
10/25/2023 7:16:42 AM
(MENAFN- Baystreet)
Danaher's Q3 Results Beat On Top And Bottom Lines
Medical device manufacturer Danaher (DHR) reported third-quarter financial results that beat Wall Street forecasts on both the top and bottom lines.
The company reported Q3 earnings per share (EPS) of $2.02 U.S. on revenue of $6.87 billion U.S.
That result was ahead of analyst estimates of $1.81 U.S. a share and revenue of $6.6 billion U.S.
The company attributed the earnings beat to higher revenue from its respiratory testing equipment, which offset softer sales in its life sciences division.
However, even though Danaher's Q3 results beat Wall Street estimates, they were lower than a year earlier.
In the same period of 2022, the company reported earnings of $2.56 U.S. a share and revenue of $7.66 billion U.S.
Danaher said that it anticipates its full-year 2023 revenue to be down slightly year-over-year.
The stock of Danaher has declined 15% year-to-date to trade at $196.84 U.S. per share.
MENAFN25102023000212011056ID1107300633
Legal Disclaimer:
MENAFN provides the information “as is” without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the provider above.